Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael B Sporn

Showing results (61-70 of 112) with videos related to

Pageof 12
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|May 13, 2014
The PARP inhibitors, veliparib and olaparib, are effective chemopreventive agents for delaying mammary tumor development in BRCA1-deficient miceCiric To, Eun-Hee Kim, Darlene B Royce, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
The synthetic triterpenoid CDDO-Imidazolide suppresses STAT phosphorylation and induces apoptosis in myeloma and lung cancer cellsKaren Liby, Nga Voong, Charlotte R Williams, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 18, 2008
Genetic or pharmacologic amplification of nrf2 signaling inhibits acute inflammatory liver injury in miceWilliam O Osburn, Melinda S Yates, Patrick D Dolan, et al.
Free Radical Biology & Medicine|May 5, 2009
Nrf2 is a critical modulator of the innate immune response in a model of uveitisNorihiro Nagai, Rajesh K Thimmulappa, Marisol Cano, et al.
European Journal of Pharmacology|August 25, 2009
Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolideSoona Shin, Junko Wakabayashi, Melinda S Yates, et al.
Biochemical and Biophysical Research Communications|November 14, 2006
Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-ImidazolideRajesh K Thimmulappa, Catherine Scollick, Kassim Traore, et al.
Carcinogenesis|October 9, 2012
The combination of the histone deacetylase inhibitor vorinostat and synthetic triterpenoids reduces tumorigenesis in mouse models of cancerKim Tran, Renee Risingsong, Darlene B Royce, et al.
Molecular Cancer Therapeutics|December 7, 2002
Identification of a novel synthetic triterpenoid, methyl-2-cyano-3,12-dioxooleana-1,9-dien-28-oate, that potently induces caspase-mediated apoptosis in human lung cancer cellsKevin B Kim, Reuben Lotan, Ping Yue, et al.
Stroke|March 31, 2012
Pharmacological induction of heme oxygenase-1 by a triterpenoid protects neurons against ischemic injuryFeng Zhang, Suping Wang, Meijuan Zhang, et al.
Clinical & Experimental Metastasis|January 15, 2011
The synthetic triterpenoid CDDO-Imidazolide suppresses experimental liver metastasisJason L Townson, Ian C Macdonald, Karen T Liby, et al.
Pageof 12

Showing results (61-70 of 112) with videos related to

Sort By:
Pageof 12
Cancer Prevention Research (Philadelphia, Pa.)|May 13, 2014
The PARP inhibitors, veliparib and olaparib, are effective chemopreventive agents for delaying mammary tumor development in BRCA1-deficient miceCiric To, Eun-Hee Kim, Darlene B Royce, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
The synthetic triterpenoid CDDO-Imidazolide suppresses STAT phosphorylation and induces apoptosis in myeloma and lung cancer cellsKaren Liby, Nga Voong, Charlotte R Williams, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 18, 2008
Genetic or pharmacologic amplification of nrf2 signaling inhibits acute inflammatory liver injury in miceWilliam O Osburn, Melinda S Yates, Patrick D Dolan, et al.
Free Radical Biology & Medicine|May 5, 2009
Nrf2 is a critical modulator of the innate immune response in a model of uveitisNorihiro Nagai, Rajesh K Thimmulappa, Marisol Cano, et al.
European Journal of Pharmacology|August 25, 2009
Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolideSoona Shin, Junko Wakabayashi, Melinda S Yates, et al.
Biochemical and Biophysical Research Communications|November 14, 2006
Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-ImidazolideRajesh K Thimmulappa, Catherine Scollick, Kassim Traore, et al.
Carcinogenesis|October 9, 2012
The combination of the histone deacetylase inhibitor vorinostat and synthetic triterpenoids reduces tumorigenesis in mouse models of cancerKim Tran, Renee Risingsong, Darlene B Royce, et al.
Molecular Cancer Therapeutics|December 7, 2002
Identification of a novel synthetic triterpenoid, methyl-2-cyano-3,12-dioxooleana-1,9-dien-28-oate, that potently induces caspase-mediated apoptosis in human lung cancer cellsKevin B Kim, Reuben Lotan, Ping Yue, et al.
Stroke|March 31, 2012
Pharmacological induction of heme oxygenase-1 by a triterpenoid protects neurons against ischemic injuryFeng Zhang, Suping Wang, Meijuan Zhang, et al.
Clinical & Experimental Metastasis|January 15, 2011
The synthetic triterpenoid CDDO-Imidazolide suppresses experimental liver metastasisJason L Townson, Ian C Macdonald, Karen T Liby, et al.
Pageof 12